The class of ATRIP activators, as defined here, is a unique and diverse group of chemicals that influence ATRIP activity indirectly through modulation of various cellular pathways, primarily those involved in DNA damage response and replication stress. These compounds do not interact with ATRIP directly but rather create cellular contexts or influence other molecular pathways that enhance the necessity or activity of ATRIP in cells. Among these, ATM inhibitors like Caffeine, KU-55933, KU-60019, and CP466722 play a pivotal role. Their inhibition of ATM kinase activity creates a cellular environment where the compensatory mechanism may lead to an increased reliance on ATR-mediated pathways, thereby indirectly enhancing ATRIP activity. This compensatory upregulation is a crucial aspect of how cells maintain genomic stability and respond to DNA damage when one pathway is inhibited or compromised.
Similarly, compounds like VE-821, although an ATR inhibitor, can paradoxically lead to situations where cellular mechanisms might attempt to compensate for the inhibited ATR activity, potentially enhancing ATRIP's role in alternative or complementary pathways. Likewise, NU6027's inhibition of CDK2, an important kinase in DNA replication and repair, may result in a similar compensatory enhancement of the ATR/ATRIP pathway.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Inhibits ATM and ATR kinases. By inhibiting ATM, it could shift cellular reliance to ATR-mediated pathways, indirectly enhancing ATRIP activity. | ||||||
LY 303511 | 154447-38-8 | sc-202215 sc-202215A | 1 mg 5 mg | $67.00 $278.00 | 3 | |
Inhibits CDK2, a kinase involved in DNA repair. Its inhibition can lead to increased reliance on ATR-mediated pathways, potentially enhancing ATRIP activity. | ||||||
ATM Kinase Inhibitor | 587871-26-9 | sc-202963 | 2 mg | $110.00 | 28 | |
An ATM inhibitor, which can lead to a compensatory increase in ATR/ATRIP-mediated DNA repair pathways as a response to DNA damage. | ||||||
KU 60019 | 925701-46-8 | sc-363284 sc-363284A | 10 mg 50 mg | $248.00 $1035.00 | 1 | |
Another ATM inhibitor, potentially causing increased dependence on ATR/ATRIP pathways for the DNA damage response. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A broad PI3K inhibitor that also inhibits ATM and ATR. Its inhibition of ATM might indirectly enhance ATR/ATRIP activity. | ||||||
MRN-ATM Pathway Inhibitor, Mirin | 299953-00-7 | sc-203144 | 10 mg | $141.00 | 4 | |
Inhibits Mre11-Rad50-Nbs1 complex, potentially shifting the balance towards ATR/ATRIP-dependent DNA repair pathways. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Causes DNA damage by inhibiting topoisomerase II, potentially activating the ATR/ATRIP pathway as part of the DNA damage response. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Induces replication stress, which is a known activator of the ATR/ATRIP pathway as part of the response to stalled replication forks. | ||||||